Douglas T. Simpson, CEO/President at CORGENIX MEDICAL CORP/CO (CONX), bought 2,161 shares at $0.42 ($908) on 2006-01-12, disclosed to the SEC on 2006-01-12.
Open-market purchase of $908 CONX by CEO/President. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| CONX | BUY | 2008-01-09 | $2K | — | Filing → |
| CONX | BUY | 2006-04-11 | $902 | — | Filing → |